SCHEMBL7380565

SCHEMBL7380565

CCCC(=O)Oc1csc(N)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
MAPT P10636 4/20 0.45
RAB9A P51151 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
NPC1 O15118 2/20 0.45
TSHR P16473 2/20 0.41
GABRA5 P31644 1/20 0.40
GABRB2 P47870 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
CA2 P00918 2/20 0.38
TP53 P04637 1/20 0.37
HTT P42858 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PKM P14618 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NOS1 P29475 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27336449 0.87 ALDH1A1 (0.47) ALDH1A1MAPTRAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL6216370 0.85 ALDH1A1 (0.50) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL27635816 0.82 ALDH1A1 (0.36) ALDH1A1MAPTRAB9AKMT2ANPC1
SCHEMBL10754839 0.82 CYP1A2 (0.39) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL11668532 0.81 ALDH1A1 (0.45) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL10755050 0.81 RAB9A (0.39) ALDH1A1MAPTRAB9AKMT2ANPC1
SCHEMBL1000856 0.78 ALDH1A1 (0.44) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL4611278 0.77 ALDH1A1 (0.56) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL10591403 0.77 ALDH1A1 (0.45) ALDH1A1MAPTRAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL11102564 0.76 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101362735-B Preparation method of ethyl 2-[[(bezyloxy)carbonyl]amido]-4-thiazolyl acetate SHANDONG JINCHENG PHARMACEUTICAL & CHEMICALS CO LTD 2011-01-05 CN claimed
CN-101541811-B Pyrazolopyrimidine Derivatives DAIICHI SANKYO CO LTD 2014-07-09 CN disclosed
CN-101130526-B Aryl carbonyl derivatives as therapeutic agents NOVO NORDISK AS 2013-07-10 CN disclosed
CN-101362735-B Preparation method of ethyl 2-[[(bezyloxy)carbonyl]amido]-4-thiazolyl acetate SHANDONG JINCHENG PHARMACEUTICAL & CHEMICALS CO LTD 2011-01-05 CN disclosed
CN-101925300-A Novel compounds as cannabinoid receptor ligands and uses thereof ABBOTT LAB 2010-12-22 CN disclosed
CN-101541811-A Pyrazolopyrimidine Derivatives DAIICHI SANKYO CO LTD (JP) 2009-09-23 CN disclosed
CN-101454302-A Thiazole compounds as cannabinoid receptor ligands and uses thereof ABBOTT LAB (US) 2009-06-10 CN disclosed
CN-101362735-A Preparation method of ethyl 2-[[(bezyloxy)carbonyl]amido]-4-thiazolyl acetate SHANDONG JINCHENG PHARMACEUTIC (CN) 2009-02-11 CN disclosed
CN-101316836-A Substituted dihydroisoindolones as allosteric modulators of glucokinase JANSSEN PHARMACEUTICA NV (BE) 2008-12-03 CN disclosed
CN-100384856-C Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity MERCK & CO INC (US) 2008-04-30 CN disclosed
CN-1249039-C Inhibitors of 11 beta-hydroxysteroid dehydrogenase type I BIOVITRUM AB (SE) 2006-04-05 CN disclosed
CN-1678311-A Arylcarbonyl derivatives useful as therapeutic agents NOVO NORDISK AS (DK) 2005-10-05 CN disclosed
CN-1543459-A Quinoline derivative and quinazoline derivative having azolyl group ������������ʽ���� 2004-11-03 CN disclosed
CN-1438997-A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I BIOVITRUM AB (SE) 2003-08-27 CN disclosed
US-6174877-B1 EXCELLANT BACTERICIDES, ORAL ABSORBABILITY AND STABILITY; IMPROVE THE STABILITY TO RENAL DEHYDROPEPTIDASE I (DHP-I); 2-(2-(N-HETEROCYCLIC-ETHYLTHIO-) DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-16 US disclosed
EP-0880511-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1999-06-16 EP disclosed
EP-0880511-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-12-02 EP disclosed
EP-0876370-A1 CARBAPENEM COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1998-11-11 EP disclosed
WO-1997026250-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-07-24 WO disclosed
WO-1997025325-A1 CARBAPENEM COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-07-17 WO disclosed